Arcadia Biosciences, Inc. research brief

CIK 1469443 Copy CIK

Generated Nov. 2, 2026, 7:55 p.m. from up to 100 stored Form D disclosures. A CIK identifies a filer, not a single offering.

Current stored business address: DALLAS TX. Reported legal jurisdiction: DELAWARE. These do not establish investor residence or where funds were deployed.

• June 26, 2026 · D · 0001469443-26-000002 · Source evidence

  Reported offering amount: 11417964 USD. Reported amount sold: 3999613 USD.

• Jan. 27, 2026 · D · 0001469443-26-000001 · Source evidence

  Reported offering amount: 6024289 USD. Reported amount sold: 2082132 USD.

Reviewed offering links

• No independently reviewed offering relationship is recorded. Adjacent filings are not assumed to belong to one offering.

Citation: Form D Explorer, “Arcadia Biosciences, Inc. research brief,” CIK 1469443, retrieved Nov. 2, 2026, 7:55 p.m.. Cite the specific accessions used. No amounts have been summed.